Source: Eur Respir J 2015; 46: 795-806
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hutchinson John, Fogarty Andrew, Hubbard Richard, McKeever Tricia. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 2015; 46: 795-806

Member's Comments

No comment yet.

Related content which might interest you: Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Source: Eur Respir J 2015; 46: 1113-1130 Year: 2015 The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Treatment of pulmonary hypertension associated with COPD: a systematic review Source: ERJ Open Res, 8 (1) 00348-2021; 10.1183/23120541.00348-2021 Year: 2022 Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 Year: 2021 Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020 Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019 Year: 2020 Global burden of COPD: systematic review and meta-analysis Source: Eur Respir J 2006; 28: 523-532 Year: 2006 Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1374-1381 Year: 2015 Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 Year: 2018 Pulmonary hypertension in COPD patients: a systematic review and meta-analysis Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Prevalence of undiagnosed COPD: systematic review and meta-analysis Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020